Perfil
Thomas Gahm has been Vice President of Research and Development for TriPath Oncology, Inc. since June, 2000.
He was Vice President of Computer Science for TriPath Imaging, Inc. from November, 1996 to May, 2000.
Previously, Dr. Gahm was Vice President of Computer Science for RIAS and RBL.
He was a Scientific Advisor and Project Coordinator of the Image Analysis Division for Kontron Electronics from 1983 to 1993.
Dr. Gahm received a degree in Engineering from the University of Stuttgart (Institute of Physical Electronics) and a PhD from the Medical and Technical University of Hannover, Germany.
Cargos activos de Thomas Gahm
| Empresas | Cargo | Inicio |
|---|---|---|
TriPath Oncology, Inc.
TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Thomas Gahm.
| Empresas | Cargo | Fin |
|---|---|---|
TriPath Imaging, Inc.
TriPath Imaging, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes molecular diagnostic products | Corporate Officer/Principal | 30/05/2000 |
Formación de Thomas Gahm.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
TriPath Imaging, Inc.
TriPath Imaging, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes molecular diagnostic products | Health Technology |
Universität Stuttgart
Universität Stuttgart Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hannover
University of Hannover Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TriPath Oncology, Inc.
TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer | Commercial Services |
- Bolsa de valores
- Insiders
- Thomas Gahm
















